These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24132903)
1. Can sodium/hydrogen exchange inhibitors be repositioned for treating attention deficit hyperactivity disorder? An in silico approach. Faraone SV; Zhang-James Y Am J Med Genet B Neuropsychiatr Genet; 2013 Oct; 162B(7):711-7. PubMed ID: 24132903 [TBL] [Abstract][Full Text] [Related]
2. Effect of disease-associated SLC9A9 mutations on protein-protein interaction networks: implications for molecular mechanisms for ADHD and autism. Zhang-James Y; Vaudel M; Mjaavatten O; Berven FS; Haavik J; Faraone SV Atten Defic Hyperact Disord; 2019 Mar; 11(1):91-105. PubMed ID: 30927234 [TBL] [Abstract][Full Text] [Related]
3. SLC9A9 mutations, gene expression, and protein-protein interactions in rat models of attention-deficit/hyperactivity disorder. Zhang-James Y; DasBanerjee T; Sagvolden T; Middleton FA; Faraone SV Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(7):835-43. PubMed ID: 21858920 [TBL] [Abstract][Full Text] [Related]
4. Structure and elevator mechanism of the mammalian sodium/proton exchanger NHE9. Winklemann I; Matsuoka R; Meier PF; Shutin D; Zhang C; Orellana L; Sexton R; Landreh M; Robinson CV; Beckstein O; Drew D EMBO J; 2020 Dec; 39(24):e105908. PubMed ID: 33118634 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of SLC9A9 and interacting molecules in the hippocampus of rat models for attention deficit/hyperactivity disorder. Zhang-James Y; Middleton FA; Sagvolden T; Faraone SV Dev Neurosci; 2012; 34(2-3):218-27. PubMed ID: 22777493 [TBL] [Abstract][Full Text] [Related]
6. Sodium hydrogen exchanger 9 NHE9 (SLC9A9) and its emerging roles in neuropsychiatric comorbidity. Patak J; Faraone SV; Zhang-James Y Am J Med Genet B Neuropsychiatr Genet; 2020 Jul; 183(5):289-305. PubMed ID: 32400953 [TBL] [Abstract][Full Text] [Related]
7. Seizures and sodium hydrogen exchangers: potential of sodium hydrogen exchanger inhibitors as novel anticonvulsants. Ali A; Ahmad FJ; Dua Y; Pillai KK; Vohora D CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):343-7. PubMed ID: 18991662 [TBL] [Abstract][Full Text] [Related]
8. Emerging roles of Na⁺/H⁺ exchangers in epilepsy and developmental brain disorders. Zhao H; Carney KE; Falgoust L; Pan JW; Sun D; Zhang Z Prog Neurobiol; 2016; 138-140():19-35. PubMed ID: 26965387 [TBL] [Abstract][Full Text] [Related]
9. Autism spectrum disorder traits in Slc9a9 knock-out mice. Yang L; Faraone SV; Zhang-James Y Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):363-76. PubMed ID: 26755066 [TBL] [Abstract][Full Text] [Related]
10. Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure. Packer M Circulation; 2017 Oct; 136(16):1548-1559. PubMed ID: 29038209 [TBL] [Abstract][Full Text] [Related]
11. Na(+)/H(+)exchangers: linking osmotic dysequilibrium to modified cell function. Ritter M; Fuerst J; Wöll E; Chwatal S; Gschwentner M; Lang F; Deetjen P; Paulmichl M Cell Physiol Biochem; 2001; 11(1):1-18. PubMed ID: 11275678 [TBL] [Abstract][Full Text] [Related]
13. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Sharma A; Couture J Ann Pharmacother; 2014 Feb; 48(2):209-25. PubMed ID: 24259638 [TBL] [Abstract][Full Text] [Related]
14. Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype. de Silva MG; Elliott K; Dahl HH; Fitzpatrick E; Wilcox S; Delatycki M; Williamson R; Efron D; Lynch M; Forrest S J Med Genet; 2003 Oct; 40(10):733-40. PubMed ID: 14569117 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells. Soleimani M; Singh G; Bookstein C; Rao MC; Chang EB; Dominguez JH J Lab Clin Med; 1996 Jun; 127(6):565-73. PubMed ID: 8648261 [TBL] [Abstract][Full Text] [Related]
16. Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1. Ahmad S; Ngu K; Combs DW; Wu SC; Weinstein DS; Liu W; Chen BC; Chandrasena G; Dorso CR; Kirby M; Atwal KS Bioorg Med Chem Lett; 2004 Jan; 14(1):177-80. PubMed ID: 14684323 [TBL] [Abstract][Full Text] [Related]
17. Different development of apical and basolateral Na-H exchangers in LLC-PK1 renal epithelial cells: characterization by inhibitors and antisense oligonucleotide. Kuwahara M; Sasaki S; Uchida S; Cragoe EJ; Marumo F Biochim Biophys Acta; 1994 Jan; 1220(2):132-8. PubMed ID: 8312357 [TBL] [Abstract][Full Text] [Related]
18. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum. Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315 [TBL] [Abstract][Full Text] [Related]
19. The presence of NHE1 and NHE3 Na+-H+ exchangers and an apical cAMP-independent Cl- channel indicate that both absorptive and secretory functions are present in calf gall bladder epithelium. Bazzini C; Bottà G; Meyer G; Baroni MD; Paulmichl M Exp Physiol; 2001 Sep; 86(5):571-83. PubMed ID: 11571484 [TBL] [Abstract][Full Text] [Related]
20. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. Karmazyn M; Sawyer M; Fliegel L Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):323-35. PubMed ID: 16101565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]